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It has been shown by Kendall, Heidelberger, and  Dawson  (1)  that  hyaluronic 
acid is one of the main components of the hemolytic streptococcus capsule.  This 
polysaecharide was originally described by Meyer and Palmer (2, 3) in vitreous humor, 
umbilical cord, and synovial fluid, and it has since been isolated from other sources, 
namely skin (4, 5), a human mesothelioma (6), and the Rous sarcoma (7).  Attempts 
to  produce  antibodies  against  this  substance  have  so  far  been  unsuccessful  and 
there would seem to be little possibility that specific serologic reactions can be used for 
its identification. 
Hyaluronic acid will unite with normal serum proteins and egg albumin at about 
pH 4  to produce an insoluble  complex.  This property originally noted by Meyer 
and Palmer (2) has been employed in a variety of ways (8, 9) to estimate the material; 
it can exclude the presence of as little as 2 gamma per co. with certainty, although it 
is obviously not a specific reaction. 
Enzymes  capable  of  hydrolyzing  hyaluronic  acid,  incidentally  destroying  the 
property of union with protein at pH 4, have been obtained from pneumococci (10, 11), 
B. welckil (10), testicular extract (12, 13), leech extract (4, 13), and from a few non- 
mucoid hemolytic streptococci (9, 13).  Such enzymes used in conjunction with the 
protein reactions noted above will give a fairly accurate impression of the presence 
and amount of the polysaccharide in impure mixtures. 
The purpose of the present study, based on the foregoing facts, was to  deter- 
mine the occurrence of hyaluronic acid, or mucoid polysaccharide, in a number 
of beta hemolytic streptococci obtained from human infections, and from nor- 
mal throats in which no subsequent infection developed. 
Materials  and Methods 
125 strains were investigated; of these, 90 were from the Wisconsin General Hospital 
and Student Infirmary,  1 obtained over a period from November, 1940, to May, 1941, 
these organisms presumably derived from infectious processes.  35 strains were from 
routine throat cultures of children  admitted to the Children's Hospital at Iowa City.  1 
In none of the latter group was any infection noted after admission. 
In addition to the mucoid polysaccharide (henceforth referred to as MP) estima- 
1 We are indebted to the staff of the Wisconsin  State Laboratory of Hygiene for its 
cooperation in obtaining the hospital strains, and to Miss Marion Jones, University of 
Iowa Medical School, for sending us the normal throat strains. 
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tions, the Lancefield group and encapsulation of each strain was determined.  The 
clinical records of the patients furnishing the 90 hospital strains were examined to 
confirm as far as possible the presence of infection as well as its severity. 
Isolation of Strains.--Pour blood plates were made with saline suspensions of the 
throat or wound swabs, and beta hemolytic colonies picked from these to streak blood 
plates to determine purity.  This second plate was the source of organisms for the 
subsequent procedures, and except as noted, no further passage on artificial medium 
was carried out.  The pour plate is desirable since 21  of the strains showed beta 
hemolysis only when under the surface of the agar, giving the alpha change on the 
surface.  This was confirmed on the secondary streak plates by incising the agar in 
the heavy portion of the  streak thus  pushing  the organisms beneath  the surface. 
Under these conditions strong beta hemolysis was observed, as in the original plate. 
The majority of the non-group A strains exhibited this behavior, although 14 of the 
21 stralnswere in group A.  The 35 normal throat strains were from triplicate streak 
plates incubated aerobically, in 10 per cent COs, and anaerobically. 
Method for OUantitating the Mucoid Polysaccharide.--In  working out a method for 
determining mucoid polysaccharide (MP)  based on the acid protein reaction, sim- 
plicity and speed were sought since the method was to be applied on a  rather large 
scale.  The material can be obtained either from neutralized 24 hour culture super- 
nates, or from very young capsulated organisms.  On heating such young organisms 
the polysaccharide is promptly released into the solution. 
At first a  one-tube method was investigated in which the turbidity developing in 
mixtures of  culture  supernates  and  acidified buffered  serum  was  compared  with 
BaSO4 standards.  Reproducible results could be achieved only with extraordinary 
attention to details of pH, salt concentration, and composition of the medium.  Since 
it was felt that the method would not be generally practicable, it was abandoned. 
Another method which was followed for a time was based on the observation that 
young capsulated organisms would agglutinate very vigorously when mixed with equal 
amounts of 0.5  ~  acetic acid.  That  the agglutination was very likely due  to the 
interaction of MP and protein was indicated by the following where it appeared that 
the bacterial body was furnishing the protein component: 24 hour  (spontaneously 
decapsulated) streptococci also agglutinated in 0.5 ~  acetic acid, but the reaction was 
abolished by 4 washings in distilled water; this did not occur with the young capsu- 
lated form.  Resuspending the old washed organisms in either the original super- 
natant  broth  or in  purified vitreous humor  hyaluronic acid solution restored the 
agglutination.  No reaction occurred in 0.5 ~ phosphate buffer at pH 7.  The mecha- 
nism of the young capsulated organism flocculation was not immediately apparent 
since the surface exposed in this case would be preponderately polysaccharide.  How- 
ever it was found that under such conditions of acidity the MP is very rapidly released 
from  the  cell with an  associated disappearance of the  capsule, the situation then 
becoming similar to that of the old culture.  A sufficient number of non-MP producing 
strains  exhibited acid  agglutination to  invalidate any  general application of  this 
as a method. 
The procedure finally adopted consisted of serial dilutions of neutralized culture 
supernatants layered over acidified normal serum, precipitation taking place at or 
above the interface.  The medium employed was bacto-neopeptone 1 per cent, bacto- C.  V.  SEASTONE  23 
beef extract 0.5 per cent, dextrose 1 per cent, NaC1 0.5 per cent, and sterile sheep 
serum  10 per cent, distributed in 5  cc. amounts in centrifuge tubes.  Inoculations 
were made from the second blood plates noted above.  After 24 hours' incubation at 
37°C., 2 drops of 0.02 per cent phenol red were added and the culture was brought 
to about pH 7.6 with 0.5 ~r NaOH.  This neutralization is essential since sufficient 
acid may be developed during growth to cause complete MP precipitation, either with 
the bacterial or serum proteins.  After centrifugation of the neutralized culture, serial 
dilutions of the clear supernatant medium in physiologic salt solution were made, 
1 : 10,  1:20,  1:40, and  1:80.  These dilutions, as well as the undiluted supernatant, 
were run into micro precipitin tubes  2 over acidified normal horse serum, and readings 
made after 1/6 hour.  The acid serum reagent was prepared in the following manner: 
Clear, non-hemolyzed horse  serum was  diluted  1:10  with 0.5  ~  acetate buffer at 
pH 4.2.  The reaction was brought to pH 3.1 with 4 ~r HC1, and merthiolate 1 : 1,000 
added to a  final concentration of 1:100,000.  It should be noted that colorimetric 
(brom cresol green) pH determinations in the presence of this amount of protein are 
extremely inaccurate, however, no significant difference in titre was noticed in a pH 
range between 3 and 4.  Uninoculated medium gave no ring at the interface.  The 
acidified serum may be stored in the cold for many months. 
Cultures reacting in a dilution higher than 1 : 80 have not been encountered.  Using 
purified hyaluronic acid from bovine vitreous humor,  an  end-point of comparable 
intensity is obtained with a  solution containing 0.002 rag. per cc.  This would indi- 
cate the presence of about 0.16 mg. per cc. of culture superuatant in a strain producing 
maximal amounts; a figure of the same order of magnitude has been found for group C 
strains by means of a  somewhat more accurate method  (8), as well as for group A 
strains by direct yield (14). 
Evaluation of MP Estimation Method.--Although it is perhaps unlikely that any of 
the recognized streptococcal somatic elements would be liberated during growth in 
large enough concentration to precipitate under the conditions of this method, the 
question of its specificity naturally arises.  It will be shown later that the majority 
of strains possessing acid serum reactivity fall into Lancefield's group A, which might 
point to the "C" substance as the responsible factor.  With this possibility in mind, 
formamide extracts (15) were prepared with A strains giving 1:80 acid serum titres, 
and from A strains in which no reaction appeared.  These extracts were tested with a 
potent A grouping serum, with the result that the latter non-MP producing strains 
reacted in slightly higher dilutions than did the former strong producers.  Further- 
more, neutralized culture supernates failed to give precipitin reactions in any dilution 
when tested with group A specific serum. 
The M  substance of Lancefield was also to be considered in the light of its known 
acid precipitability.  The following findings tend to eliminate this and the C  sub- 
stance as sources of error.  Neutralized (pH 6 in this case) culture supernates were 
prepared from 31  strains, including all degrees of acid serum reactivity.  Treating 
these with hyaluronidase from a  Type I  pneumococcus  (10,  11)  either eliminated 
completely, or reduced to a faint trace, the acid serum precipitate in all but one of the 
2 About 1 inch long from tubing 3 to 4 mm. inside diameter.  Such tubes are used 
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31 tested.  This one reacted in a dilution of 1 : 10 before and after enzyme treatment. 
From the foregoing it may be concluded  that in almost all instances the estimation 
method given here is reasonably reliable. 
F.ncapsulation.--Before neutralization of the 24 hour culture, 0.2 cc. were inocu- 
lated into 2.0 cc. of the medium described above in which  50 per cent defibrinated 
sheep blood was substituted for the serum.  After incubation for 3½ hours at 37°C., 
Wright's stained films were prepared. 
Lancefield Grouping.--The formamide micro method described by Fuller (15) was 
used on organisms from serum-free broth. 
FINDINGS 
In addition to MP determinations, Lancefield grouping, and capsule stains, 
the type of colony appearing on freshly prepared neopeptone blood agar as 
recommended by Dawson, Hobby, and Olmstead (16), and the nature of the 
growth in 10 per cent serum broth were noted.  Streptococci failing to produce 
the MP factor almost invariably remained glossy.  However, among the strains 
producing  this material,  many were encountered  which  also  showed no  dis- 
turbance of the colonial surface.  Furthermore in those strains showing flat- 
tening, crater formation, or roughening of the surface, one could not correlate 
the degree of this change with the amount of MP produced. 
Concerning  the  growth  in  10  per  cent  serum broth,  there  was a  distinct 
tendency for the  non-producing  strains to  show an extremely granular  type 
of growth,  while  the  MP  producers remained  uniformly suspended.  These 
observations were made on neutralized cultures to eliminate the effect of MP- 
protein precipitates.  In our particular group of strains this could be regarded 
only as a tendency, the most common exception being the frequent occurrence 
of non-MP producing strains which  grew as very uniform suspensions under 
these  conditions. 
The results appear in Table I from which several facts may be demonstrated. 
All the strains showing positive reactions in the 1 : 40 to 1 : 80 range of dilution 
may be shown to be capsulated.  In the 1 : 20 range, capsules appear irregularly, 
and below 1:20 no stainable capsule could be found.  In general, the largest 
capsules appeared in the 1 : 80 group but it was not always possible to correlate 
capsular size with MP titre.  Different strains retain their capsules with vary- 
ing degrees of tenacity, and exhibit different growth rates.  It would therefore 
be unwise  to assume  that  any one arbitrary incubation  period  would  allow 
optimal capsulation of all strains.  Of the 42 non-group A strains,  3 not one was 
found  to  produce  detectable  amounts  of  mucoid  polysaccharide.  The  dis- 
tribution of group A  strains in the hospital compared with the normal throat 
strains is noteworthy, confirming the well established observation of Lancefield 
(17) that most streptococcal infections in man are due to this group.  Of the 
8 These were in groups B and C with one exception which could not be classified. C,  V.  SEASTON"E  25 
35  strains  from normal  throats  only 3  were MP  producers,  all of them cap- 
sulated and belonging to Lancefield's group A.  No other group A strains were 
encountered here.  In sharp contrast are the 90 hospital strains; if one disre- 
gards the 8  strains which were not associated with infection,  78 of 82 strains 
are group A, and  72 are MP producers. 
In evaluating the  severity of the  infections it  is fully recognized that  the 
virulence  of the organism is not the only factor involved.  Of perhaps equal 
importance in affecting the clinical picture is the individual host resistance as 
well  as  the  sulfonamide  therapy  which  most  of  the  patients  received.  In 
TABLE I 
Distribution of Mucoid Polysaccharide 
Titre in acid serum  1:40 to 1:80  1:20  1:10  Undilutedor  0 
90 hospital and infirmary strains 
No. of strains ............................... 
Showing capsules ............................ 
Lancefield group A .......................... 
From severe infections ....................... 
From moderate infections .................... 
From mild or doubtful infections .............. 
Giving no clinical evidence of infection ........ 
51 
51 
51 
14 
29 
8 
0 
15 
12 
15 
2 
11 
2 
0 
6 
?1 
6 
1" 
4 
1 
0 
18 
?1 
6 
0 
5 
5 
8 
35 normal throat strains 
No. of strains ...............................  2  1  0  32 
Showing capsules ............................  2  i  0 
Lancefield group A ..........................  2  1  0 
* Complicated by Staphylococcus  aureus. 
spite of these limitations the infections were grouped as severe, moderate, and 
mild.  It was of interest that a certain number of the strains were derived from 
patients showing no clinical or pathological evidence of streptococcal infection. 
The group of severe infections comprised those showing a septic febrile course, 
a  positive blood culture, or a  particularly protracted illness with or  without a 
spiking temperature curve.  All exhibited marked leukocytosis.  Four of these 
infections were fatal, and one required amputation of a limb.  In the moderate 
group were placed infections of rather shorter duration and less alarming nature. 
Most  of these  were acute  sore throats with  more or less intense  pharyngeal 
injection,  and  a  3  to  5  day temperature  elevation,  often followed by  otitis 
media.  It is not certain that all of the so called mild cases were of strepto- 
coccal etiology.  They were  usually  transitory  sore throats  with  a  24 to 48 
hour  febrile  period  sometimes  without  leukocytosis  or  marked  pharyngeal 26  M'UCOID POL¥SACCIIA_RIDE IN IIEMOL~rTIC STREPTOCOCCI 
inflammation.  One of them was an otitis media in a  diabetic child aged  7, 
who remained afebrile throughout the course of the illness. 
As is shown in the table, there is a progressive decrease in the proportion of 
high MP-producing strains as one goes from the severe types of infection to the 
mild ones.  No fatalities occurred due to strains precipitating in a titre of less 
than 1:40.  Although the numbers were too small to have much significance, 
a relatively greater proportion of children were infected with organisms of low 
MP content. 
DISCUSSION 
The data presented above tend to confirm the impression that most serious 
human  hemolytic streptococcal infections are  due  to  organisms  in  a  phase 
described by Dawson  (16)  as mucoid,  and by Todd and Lancefield (18)  as 
matt, these designations very likely being synonymous.  The important factor 
in the matt designation has been the M  substance, while the common factor 
indicated by Dawson and others as associated with mucoid strains is the mucoid 
polysaccharide,  or hyaluronic acid,  presumably a  capsular  substance.  The 
latter has not been sought in any very large number of human strains, and it is 
not impossible that these two substances are invariably associated in any matt, 
or mucoid strain.  The present work shows the wide distribution of the mucoid 
polysaccharide in streptococci from man, and the wide variation in the amounts 
appearing in different strains.  In the absence of a  more or less quantitative 
study,  many  of  these  strains,  although  producing  appreciable  amounts  of 
polysaccharide, would not ordinarily be classified as mucoid, indeed they could 
not under the current description of this phase. 
Lancefield has shown that the protein M  substance is partly responsible for 
type specificity in group A streptococci, and for the protective effect of anti- 
sera and vaccines.  There is evidence that the anti-M antibody brings about 
opsonization of  capsulated  organisms;  this  has  been  suggested  as  a  typing 
method (19).  These facts would constitute good evidence that the M substance 
is responsible for virulence were it not for the observation that this material 
may be obtained in equally large amounts from avirulent strains (20).  That 
one might stimulate protective antibodies with a substance not itself responsi- 
ble for virulence is conceivable, recalling the non-type specific immunity ob- 
tained with the pneumococcus (21). 
The possibility that the mucoid polysaccharide may play a part in virulence 
is raised in the first place by its capsular location; the fact that capsular autol- 
ysis is associated with  the appearance of spontaneous pbagocytosis in normal 
blood is also suggestive (22).  Hirst (14) has studied the effect of leech hyalu- 
ronidase on protection.  He was  able to show that this enzyme which causes 
rapid decapsulation in strains of either group A or C, is protective only for mice 
infected with group C  strains, and it was  concluded from this (23)  that the C.  V.  S~ASTOm~  27 
capsular substance plays little or no part in  the virulence of group A  strains. 
Using another source of hyaluronidase, an  extract of beef testis, we have ob- 
tained essentially the same results  with the same strains employed by Hirst, 
however it has been our experience that group C organisms of guinea pig origin 
are less rapidly fatal than are group A  strains.  The average time of death 
for the latter is around 24 hours, while the fatal period for group C infections 
is nearer 48 hours.  With this in mind as a possible explanation for the differ- 
ences in therapeutic effect, we repeated the experiment using larger amounts of 
enzyme at more frequent intervals, and obtained permanent protection in group 
A (S 23) infections involving between  10 and  100  ~.L.D.  This effect is men- 
tioned only in a preliminary way for the purpose of discussion; more detailed 
study is in progress. 
These findings point  to the mucoid polysaccharide as  a  factor of definite 
significance in the virulence of hemolytic streptococci of human origin. 
SUMMARY 
1.  A rapid method for the roughly quantitative estimation of mucoid poly- 
saccharide in hemolytic streptococci has been described. 
2.  Using this method, about 94 per cent of strains from moderate or severe 
streptococcal infections in man have been found to produce mucoid polysac- 
charide in greater or less amount.  In a  group of streptococci from normal 
throats only about 8 per cent produced this substance,  all of the producers 
falling into Lancefield's group A. 
3.  Of the Lancefield group A strains from both normal and infected sources, 
92 per cent showed the presence of mucoid polysaccharide in culture dilutions 
of 1 : 10 or higher. 
4.  The probable significance of the mucoid polysaccharide in streptococcal 
virulence is indicated. 
We are indebted to Mr. E. H. Kass for much assistance  in this work, particularly 
in connection with the enzyme preparations. 
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